Liquid melevodopa versus standard levodopa in patients with Parkinson disease and small intestinal bacterial overgrowth

Maurizio Gabrielli; Enzo Ragazzoni; Annalisa Tortora; Maria Assunta Zocco; Antonio Gasbarrini; Anna Rita Bentivoglio

doi:10.1097/WNF.0000000000000034

Liquid melevodopa versus standard levodopa in patients with Parkinson disease and small intestinal bacterial overgrowth

Maurizio Gabrielli, Enzo Ragazzoni, Annalisa Tortora, Maria Assunta Zocco, Antonio Gasbarrini, Anna Rita Bentivoglio

Risultato della ricerca: Contributo in rivista › Articolo in rivista

14 Citazioni (Scopus)

Abstract

Patients with Parkinson disease exhibit a highly increased prevalence of small intestinal bacterial overgrowth (SIBO), which has been also associated with the severity of motor fluctuations. Aim of this study was to test the efficacy of liquid levodopa with higher bioavailability in patients with SIBO.

Lingua originale	English
pagine (da-a)	91-95
Numero di pagine	5
Rivista	Clinical Neuropharmacology
Volume	37
DOI	https://doi.org/10.1097/WNF.0000000000000034
Stato di pubblicazione	Pubblicato - 2014

Keywords

bacterial overgrowth
liquid melevodopa

Accesso al documento

10.1097/WNF.0000000000000034

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

@article{c11ecb05a75f42c4aef10fea009d87b2,

title = "Liquid melevodopa versus standard levodopa in patients with Parkinson disease and small intestinal bacterial overgrowth",

abstract = "Patients with Parkinson disease exhibit a highly increased prevalence of small intestinal bacterial overgrowth (SIBO), which has been also associated with the severity of motor fluctuations. Aim of this study was to test the efficacy of liquid levodopa with higher bioavailability in patients with SIBO.",

keywords = "bacterial overgrowth, liquid melevodopa, bacterial overgrowth, liquid melevodopa",

author = "Maurizio Gabrielli and Enzo Ragazzoni and Annalisa Tortora and Zocco, {Maria Assunta} and Antonio Gasbarrini and Bentivoglio, {Anna Rita}",

year = "2014",

doi = "10.1097/WNF.0000000000000034",

language = "English",

volume = "37",

pages = "91--95",

journal = "Clinical Neuropharmacology",

issn = "0362-5664",

publisher = "Lippincott Williams and Wilkins",

}

TY - JOUR

T1 - Liquid melevodopa versus standard levodopa in patients with Parkinson disease and small intestinal bacterial overgrowth

AU - Gabrielli, Maurizio

AU - Ragazzoni, Enzo

AU - Tortora, Annalisa

AU - Zocco, Maria Assunta

AU - Gasbarrini, Antonio

AU - Bentivoglio, Anna Rita

PY - 2014

Y1 - 2014

N2 - Patients with Parkinson disease exhibit a highly increased prevalence of small intestinal bacterial overgrowth (SIBO), which has been also associated with the severity of motor fluctuations. Aim of this study was to test the efficacy of liquid levodopa with higher bioavailability in patients with SIBO.

AB - Patients with Parkinson disease exhibit a highly increased prevalence of small intestinal bacterial overgrowth (SIBO), which has been also associated with the severity of motor fluctuations. Aim of this study was to test the efficacy of liquid levodopa with higher bioavailability in patients with SIBO.

KW - bacterial overgrowth

KW - liquid melevodopa

KW - bacterial overgrowth

KW - liquid melevodopa

UR - http://hdl.handle.net/10807/60732

U2 - 10.1097/WNF.0000000000000034

DO - 10.1097/WNF.0000000000000034

M3 - Article

SN - 0362-5664

VL - 37

SP - 91

EP - 95

JO - Clinical Neuropharmacology

JF - Clinical Neuropharmacology

ER -

Liquid melevodopa versus standard levodopa in patients with Parkinson disease and small intestinal bacterial overgrowth

Abstract

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo